These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 21549099)

  • 1. Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.
    Park JH; Park SM; Park KH; Cho KH; Lee ST
    Biochem Biophys Res Commun; 2011 May; 409(1):58-63. PubMed ID: 21549099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.
    Park JY; Park JH; Jang W; Hwang IK; Kim IJ; Kim HJ; Cho KH; Lee ST
    J Biochem; 2012 Mar; 151(3):291-8. PubMed ID: 22170214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14.
    Park JH; Park SM; Park SH; Cho KH; Lee ST
    Proteomics; 2008 Jul; 8(14):2926-35. PubMed ID: 18655030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of plasma gelsolin as a substrate for matrix metalloproteinases.
    Park SM; Hwang IK; Kim SY; Lee SJ; Park KS; Lee ST
    Proteomics; 2006 Feb; 6(4):1192-9. PubMed ID: 16421935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases.
    Kim SY; Park SM; Lee ST
    Biochem Biophys Res Commun; 2006 Jan; 339(1):47-54. PubMed ID: 16314153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
    Nakabayashi T; Yamauchi K; Sugano M; Sano K; Tozuka M; Hidaka H
    Ann Clin Lab Sci; 2004; 34(3):287-98. PubMed ID: 15487703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading.
    Silva RA; Hilliard GM; Fang J; Macha S; Davidson WS
    Biochemistry; 2005 Mar; 44(8):2759-69. PubMed ID: 15723520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
    Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
    Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal (1-44) and C-terminal (198-243) peptides of apolipoprotein A-I behave differently at the triolein/water interface.
    Wang L; Hua N; Atkinson D; Small DM
    Biochemistry; 2007 Oct; 46(43):12140-51. PubMed ID: 17915945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial expression and characterization of chicken apolipoprotein A-I.
    Kiss RS; Kay CM; Ryan RO
    Protein Expr Purif; 1998 Apr; 12(3):353-60. PubMed ID: 9535703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
    Fang Y; Gursky O; Atkinson D
    Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A-I, a hyperosmotic adaptation-related protein in ayu (Plecoglossus altivelis).
    Chen J; Shi YH; Hu HQ; Niu H; Li MY
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Feb; 152(2):196-201. PubMed ID: 19095077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.
    Seraglia R; Sartore G; Marin R; Burlina S; Manzato E; Ragazzi E; Traldi P; Lapolla A
    J Mass Spectrom; 2013 Jan; 48(1):105-10. PubMed ID: 23303753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence of horse (Equus caballus) apoA-II. Another example of a dimer forming apolipoprotein.
    Puppione DL; Fischer WH; Park M; Whitelegge JP; Schumaker VN; Golfeiz S; MacDonald MH
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Jul; 138(3):213-20. PubMed ID: 15253869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I.
    Safi W; Maiorano JN; Davidson WS
    J Lipid Res; 2001 May; 42(5):864-72. PubMed ID: 11352994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.